Literature DB >> 30560938

Two novel quinomycins discovered by UPLC-MS from Stretomyces sp. HCCB11876.

Zhijun Yang1, Lei Shao1, Meixia Wang2, Min Rao3, Mei Ge4, Yixin Xu5.   

Abstract

Two novel quinomycins I (1) and J (3) were discovered by UPLC-MS, then the two novel compounds and five known quinomycins A(2), B(4), E(5), C(6) and monosulfoxide quinomycin (7) were isolated from the culture broth of Streptomyces sp. HCCB11876. The structures of these compounds were elucidated through MS and NMR spectroscopic analysis. Compounds 1-7 showed significant antibacterial and cytotoxic activities. The structure-activity relationship indicated that sulfoxide group in N-methylcysteine of quinomycins (1, 3 and 7) would significantly decrease the antibacterial and cytotoxic activities. Moreover, the antibacterial and cytotoxic activities were decreased with the increase of carbon chain in amino-acid residues.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30560938     DOI: 10.1038/s41429-018-0132-1

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

Review 1.  Type II non-ribosomal peptide synthetase proteins: structure, mechanism, and protein-protein interactions.

Authors:  Matt J Jaremko; Tony D Davis; Joshua C Corpuz; Michael D Burkart
Journal:  Nat Prod Rep       Date:  2020-03-25       Impact factor: 13.423

2.  Exploitation of Potentially New Antibiotics from Mangrove Actinobacteria in Maowei Sea by Combination of Multiple Discovery Strategies.

Authors:  Qin-Pei Lu; Jing-Jing Ye; Yong-Mei Huang; Di Liu; Li-Fang Liu; Kun Dong; Elizaveta A Razumova; Ilya A Osterman; Petr V Sergiev; Olga A Dontsova; Shu-Han Jia; Da-Lin Huang; Cheng-Hang Sun
Journal:  Antibiotics (Basel)       Date:  2019-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.